Olympus Announces Co-Development Agreement with AI4GI

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced its co-development agreement with AI4GI, a commercial joint venture between Satis Operations and Imagia. Their Artificial Intelligence (AI) solution for real-time clinical decision support during screening and surveillance colonoscopy procedures will be exclusively offered by Olympus America Inc. (OAI). This co-development agreement is intended to raise the bar for all physicians to ultimately improve clinical outcomes, reduce overall costs and enhance the quality of life for patients. 

Related posts

A Two-Stream Continual Learning System With Variational Domain-Agnostic Feature Replay

A Two-Stream Continual Learning System With Variational Domain-Agnostic Feature Replay

Lao, Qicheng, Xiang Jiang, Mohammad Havaei, and Yoshua Bengio.IEEE Transactions on Neural Networks and Learning Systems (2021).


...
Read more
Imagia secures an additional $7M of funding  from Québec to further accelerate the development of its EVIDENS  platform

Imagia secures an additional $7M of funding from Québec to further accelerate the development of its EVIDENS platform

Imagia, a leader in artificial intelligence and personalized healthcare announced today a $7M support from Investissement Québec as part of

...
Read more
How HDMI supports groundbreaking possibilities in healthcare

How HDMI supports groundbreaking possibilities in healthcare

The process of labeling data is costly, tedious and is a very manual task  tackled by humans. Current machine learning algorithms require a

...
Read more